AVID100 in Advanced Epithelial Carcinomas
NCT03094169
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
49
Enrollment
INDUSTRY
Sponsor class
Stopped
lack of efficacy
Conditions
Solid Tumor, Adult
Triple Negative Breast Cancer
Head and Neck Squamous Cell Carcinoma
Non Small Cell Lung Cancer
Interventions
DRUG:
AVID100 IV
Sponsor
Formation Biologics